NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky is commencing an investigation into the Board of Directors of Hospira Inc. (“Hospira” or “the Company”) (NYSE:HSP) in connection with possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pfizer.
Click here to learn more about the investigation: http://zlk.9nl.com/hospira.
Under the terms of the transaction, Hospira shareholders will receive $90 in cash for each share of Hospira stock they own. The investigation concerns whether the Board of Hospira breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Pfizer is underpaying for Hospira shares.
If you own Hospira common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/hospira.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.